Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples

Journal of Immunological Methods

Volumn 408, Issue , 2014, Pages 13-23

  Bastarache, J A ^a   Koyama, T ^a   Wickersham, N E ^a   Ware, L B ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarkers; Bronchoalveolar lavage; ELISA; Immunoassay; Plasma

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CHEMILUMINESCENCE IMMUNOASSAY; CONTROLLED STUDY; CRITICALLY ILL PATIENT; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LUNG LAVAGE; MOUSE; MULTIPLEX ELECTROCHEMILUMINESCENT IMMUNOASSAY; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VALIDATION STUDY;

BIOMARKERS; BRONCHOALVEOLAR LAVAGE; ELISA; IMMUNOASSAY; PLASMA;

ANIMALS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; ELECTROCHEMICAL TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; LIMIT OF DETECTION; LUMINESCENT MEASUREMENTS; MICE; MICE, INBRED C57BL; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SPECIES SPECIFICITY;

EID: 84903437288     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2014.04.006     Document Type: Article

References (34)

1. Bafadhel M., McCormick M., Saha S., McKenna S., Shelley M., Hargadon B., Mistry V., Reid C., Parker D., Dodson P., Jenkins M., Lloyd A., Rugman P., Newbold P., Brightling C.E. Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease. Respiration 2012, 83:36.
2. Bastarache J.A., Koyama T., Wickersham N.E., Mitchell D.B., Mernaugh R.L., Ware L.B. Accuracy and reproducibility of a multiplex immunoassay platform: a validation study. J. Immunol. Methods 2011, 367:33.
3. Bastarache J.A., Sebag S.C., Clune J.K., Grove B.S., Lawson W.E., Janz D.R., Roberts J.L., Dworski R., Mackman N., Ware L.B. Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress. Thorax 2012, 67:8.
4. Bea J.W., Wright N.C., Thompson P., Hu C., Guerra S., Chen Z. Performance evaluation of a multiplex assay for future use in biomarker discovery efforts to predict body composition. Clin. Chem. Lab. Med. 2011, 49:817.
5. Belabani C., Rajasekharan S., Poupon V., Johnson T., Bar-Or A. A condensed performance-validation strategy for multiplex detection kits used in studies of human clinical samples. J. Immunol. Methods 2013, 387:1.
6. Breen E.C., Reynolds S.M., Cox C., Jacobson L.P., Magpantay L., Mulder C.B., Dibben O., Margolick J.B., Bream J.H., Sambrano E., Martinez-Maza O., Sinclair E., Borrow P., Landay A.L., Rinaldo C.R., Norris P.J. Multisite comparison of high-sensitivity multiplex cytokine assays. Clin. Vaccine Immunol. 2011, 18:1229.
7. Calfee C.S., Eisner M.D., Parsons P.E., Thompson B.T., Conner E.R., Matthay M.A., Ware L.B. Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med. 2009, 35(2):248-257. (Feb).
8. Chandra P.E., Sokolove J., Hipp B.G., Lindstrom T.M., Elder J.T., Reveille J.D., Eberl H., Klause U., Robinson W.H. Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthritis Res. Ther. 2011, 13:R102.
9. Chowdhury F., Williams A., Johnson P. Validation and comparison of two multiplex technologies, Luminex and Mesoscale Discovery, for human cytokine profiling. J. Immunol. Methods 2009, 340:55.
10. Christie J.D., Shah C.V., Kawut S.M., Mangalmurti N., Lederer D.J., Sonett J.R., Ahya V.N., Palmer S.M., Wille K., Lama V., Shah P.D., Shah A., Weinacker A., Deutschman C.S., Kohl B.A., Demissie E., Bellamy S., Ware L.B. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am. J. Respir. Crit. Care Med. 2009, 180:1010.
11. Discovery, M.S. 2012. In.
12. Dossus L., Becker S., Achaintre D., Kaaks R., Rinaldi S. Validity of multiplex-based assays for cytokine measurements in serum and plasma from "non-diseased" subjects: comparison with ELISA. J. Immunol. Methods 2009, 350:125.
13. Eastman P.S., Manning W.C., Qureshi F., Haney D., Cavet G., Alexander C., Hesterberg L.K. Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis. J. Pharm. Biomed. Anal. 2012, 70:415.
14. Ellington A.A., Kullo I.J., Bailey K.R., Klee G.G. Measurement and quality control issues in multiplex protein assays: a case study. Clin. Chem. 2009, 55:1092.
15. Ellington A.A., Kullo I.J., Bailey K.R., Klee G.G. Antibody-based protein multiplex platforms: technical and operational challenges. Clin. Chem. 2010, 56:186.
16. Fu Q., Zhu J., Van Eyk J.E. Comparison of multiplex immunoassay platforms. Clin. Chem. 2010, 56:314.
17. Janz D.R., Bastarache J.A., Sills G., Wickersham N., May A.K., Bernard G.R., Ware L.B. Association between haptoglobin, hemopexin and mortality in adults with sepsis. Crit. Care 2013, 17:R272.
18. Keustermans G.C., Hoeks S.B., Meerding J.M., Prakken B.J., de Jager W. Cytokine assays: an assessment of the preparation and treatment of blood and tissue samples. Methods 2013, 61:10.
19. Kragstrup T.W., Vorup-Jensen T., Deleuran B., Hvid M. A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. Springerplus 2013, 2:263.
20. Li D., Chiu H., Gupta V., Chan D.W. Validation of a multiplex immunoassay for serum angiogenic factors as biomarkers for aggressive prostate cancer. Clin. Chim. Acta 2012, 413:1506.
21. Mitsunaga S., Ikeda M., Shimizu S., Ohno I., Furuse J., Inagaki M., Higashi S., Kato H., Terao K., Ochiai A. Serum levels of IL-6 and IL-1beta can predict the efficacy of gemcitabine in patients with advanced pancreatic cancer. Br. J. Cancer 2013, 108:2063.
22. Ostendorff H.P., Awad A., Braunschweiger K.I., Liu Z., Wan Z., Rothschild K.J., Lim M.J. Multiplexed VeraCode bead-based serological immunoassay for colorectal cancer. J. Immunol. Meth. 2013, 400-401:58-69. (Dec 31).
23. Ravindran R., Khan I.H., Krishnan V.V., Ziman M., Kendall L.V., Frasier J.M., Bates R., Griffey S.M., Fahey J.R., Luciw P.A. Validation of multiplex microbead immunoassay for simultaneous serodetection of multiple infectious agents in laboratory mouse. J. Immunol. Methods 2010, 363:51.
24. Richens J.L., Urbanowicz R.A., Metcalf R., Corne J., O'Shea P., Fairclough L. Quantitative validation and comparison of multiplex cytokine kits. J. Biomol. Screen. 2010, 15:562.
25. Salvante K.G., Brindle E., McConnell D., O'Connor K., Nepomnaschy P.A. Validation of a new multiplex assay against individual immunoassays for the quantification of reproductive, stress, and energetic metabolism biomarkers in urine specimens. Am. J. Hum. Biol. 2012, 24:81.
26. Siew E.D., Ikizler T.A., Gebretsadik T., Shintani A., Wickersham N., Bossert F., Peterson J.F., Parikh C.R., May A.K., Ware L.B. Elevated urinary IL-18 levels at the time of ICU admission predict adverse clinical outcomes. Clin. J. Am. Soc. Nephrol. 2010, 5:1497.
27. Sloan J.H., Siegel R.W., Ivanova-Cox Y.T., Watson D.E., Deeg M.A., Konrad R.J. A novel high-sensitivity electrochemiluminescence (ECL) sandwich immunoassay for the specific quantitative measurement of plasma glucagon. Clin. Biochem. 2012, 45:1640.
28. Sun M., Manolopoulou J., Spyroglou A., Beuschlein F., Hantel C., Wu Z., Bielohuby M., Hoeflich A., Liu C., Bidlingmaier M. A microsphere-based duplex competitive immunoassay for the simultaneous measurements of aldosterone and testosterone in small sample volumes: validation in human and mouse plasma. Steroids 2010, 75:1089.
29. Toedter G., Hayden K., Wagner C., Brodmerkel C. Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis. Clin. Vaccine Immunol. 2008, 15:42.
30. Valentin M.A., Ma S., Zhao A., Legay F., Avrameas A. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies. J. Pharm. Biomed. Anal. 2011, 55:869.
31. van Bussel B.C., Ferreira I., van de Waarenburg M.P., van Greevenbroek M.M., van der Kallen C.J., Henry R.M., Feskens E.J., Stehouwer C.D., Schalkwijk C.G. Multiple inflammatory biomarker detection in a prospective cohort study: a cross-validation between well-established single-biomarker techniques and an electrochemiluminescense-based multi-array platform. PLoS One 2013, 8:e58576.
32. Ware L.B., Koyama T., Billheimer D.D., Wu W., Bernard G.R., Thompson B.T., Brower R.G., Standiford T.J., Martin T.R., Matthay M.A. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury. Chest 2010, 137:288.
33. Ware L.B., Koyama T., Zhao Z., Janz D.R., Wickersham N., Bernard G.R., May A.K., Calfee C.S., Matthay M.A. Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome. Crit. Care 2013, 17:R253.
34. Zhang X., Gibson B., Mori R., Snow-Lisy D., Yamaguchi Y., Campbell S.C., Simmons M.N., Daly T.M. Analytical and biological validation of a multiplex immunoassay for acute kidney injury biomarkers. Clin. Chim. Acta 2013, 415:88.